Evidence map›Paper›PMID 35727988›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Functionally linked potassium channel activity in cerebral endothelial and smooth muscle cells is compromised in Alzheimer's disease.

Jade L Taylor, Harry A T Pritchard, Katy R Walsh, Patrick Strangward, Claire White, David Hill-Eubanks, Mariam Alakrawi, Grant W Hennig, Stuart M Allan, Mark T Nelson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. SIEVEseq: unified differential expression, variability, and skewness analyses using RNA-Seq data.DNA research : an international journal for rapid publication of reports on genes and genomes · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Amyloid β alters vascular CaThe Journal of physiology · 2025
    Article
  9. Review
  10. Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Vascular Function and Ion Channels in Alzheimer's Disease.Microcirculation (New York, N.Y. : 1994) · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jade L TaylorDivision of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom.
Harry A T PritchardDivision of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom.ORCID 0000-0003-2408-0909
Katy R WalshDivision of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom.
Patrick StrangwardGeoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester M13 9PL, United Kingdom.
Claire WhiteGeoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester M13 9PL, United Kingdom.
David Hill-EubanksDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405.
Mariam AlakrawiDivision of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom.
Grant W HennigDepartment of Pharmacology, Larner College of Medicine, University of Vermont, Burlington, VT 05405.
Stuart M AllanGeoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance NHS Group, University of Manchester, Manchester M13 9PL, United Kingdom.ORCID 0000-0001-9646-4456
Mark T NelsonDivision of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom.
Adam S GreensteinDivision of Cardiovascular Sciences, Faculty of Biology, Medicine, and Health, University of Manchester & Manchester University Teaching Hospitals NHS Foundation Trust, Manchester M13 9PL, United Kingdom.
Manchester Academic Health Science Centre · GBUniversity of Vermont · USManchester University NHS Foundation Trust · GB

Funding

Vermont Center for Cardiovascular and Brain HealthP20GM135007 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Diego Adrianzen Herrera · 2020 to 2026
$17.4M
Capillaries as a Sensory Web that Controls Cerebral Blood Flow in Health and DiseaseR35HL140027 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2019 to 2025
$6.3M
Cerebral Microvascular Signaling and Neurovascular Coupling: An Integrated Approach to Investigate VCIDR01NS119971 · NINDS · FLORIDA INTERNATIONAL UNIVERSITY · PI TSOUKIAS, NIKOLAOS MICHAEL · 2021 to 2025
$2.6M
Ion Channel Dysfunction in Small Vessel Disease of the BrainR01NS110656 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2019 to 2023
$2.6M
British Heart Foundation PG/18/7/33535British Heart Foundation (BHF) AA/18/4/34221British Heart Foundation (BHF) FS/19 /8/34163British Heart Foundation (BHF) PG/18/7/33535HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R35-HL-140027HHS | NIH | National Institute of General Medical Sciences (NIGMS) P20-GM-135007HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS-110656HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01-NS-119971NHLBI NIH HHS R35 HL140027NIGMS NIH HHS P20 GM135007NINDS NIH HHS R01 NS110656NINDS NIH HHS R01 NS119971
6 · The paper itself

Abstract

The brain microcirculation is increasingly viewed as a potential target for disease-modifying drugs in the treatment of Alzheimer's disease patients, reflecting a growing appreciation of evidence that cerebral blood flow is compromised in such patients. However, the pathogenic mechanisms in brain resistance arteries underlying blood flow defects have not yet been elucidated. Here we probed the roles of principal vasodilatory pathways in cerebral arteries using the APP23 mouse model of Alzheimer's disease, in which amyloid precursor protein is increased approximately sevenfold, leading to neuritic plaques and cerebrovascular accumulation of amyloid-β similar to those in patients with Alzheimer's disease. Pial arteries from APP23 mice (18 mo old) exhibited enhanced pressure-induced (myogenic) constriction because of a profound reduction in ryanodine receptor-mediated, local calcium-release events ("Ca

Indexed as

Alzheimer DiseaseBrainCalcium SignalingLarge-Conductance Calcium-Activated Potassium ChannelsMuscle, Smooth, VascularMyocytes, Smooth MuscleAnimalsCerebral ArteriesDisease Models, AnimalHumansMiceVasodilationLarge-Conductance Calcium-Activated Potassium ChannelsAlzheimer’scalcium signalingpotassium channelsmall artery

Identifiers

PMID35727988
PMCPMC9245656
OpenAlexW4283206489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.